Galapagos Company
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Industry:
AI, Clinical Development
Headquarters:
Mechelen-bovelingen, Limburg, Belgium
Founded Date:
1999-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
6
Total Funding:
5446287155
Estimated Revenue:
$100M to $500M
Last Funding Date:
2019-07-14
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership